Lv1
20 积分 2025-09-24 加入
An Updated Review of Novel Triglyceride-Lowering Therapies in Adults with Familial Chylomicronemia Syndrome
2个月前
已完结
Pharmacodynamic Effect of ARO-APOC3, an Investigational Hepatocyte-targeted RNA Interference Therapeutic Targeting Apolipoprotein C3, in Patients With Hypertriglyceridemia and Multifactorial Chylomicronemia
2个月前
已关闭
Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?
2个月前
已完结
Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications
2个月前
已完结
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
2个月前
已完结
Fitusiran: First Approval
2个月前
已完结
Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins
2个月前
已完结
IL-1 pathways in inflammation and human diseases
3个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
4个月前
已完结
Metabolic dysfunction-associated steatotic liver disease in children
4个月前
已完结
皖公网安备34019202002308
